Non-nosocomial healthcare-associated infective endocarditis in Taiwan: An underrecognized disease with poor outcome

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Wu, Kuan Sheng ^a   Lee, Susan S ^a,b   Tsai, Hung Chin ^a,b   Wann, Shue Ren ^a   Chen, Jui Kuang ^a   Sy, Cheng Len ^a   Wang, Yung Hsin ^a   Tseng, Yu Ting ^a   Chen, Yao Shen ^a,b,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED INFECTIVE ENDOCARDITIS; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORTALITY; NON NOSOCOMIAL HEALTHCARE ASSOCIATED INFECTIVE ENDOCARDITIS; NONHUMAN; NOSOCOMIAL INFECTIVE ENDOCARDITIS; OUTCOME ASSESSMENT; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK; STAPHYLOCOCCUS AUREUS; TAIWAN; BACTERIUM; CLASSIFICATION; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CROSS INFECTION; ENDOCARDITIS; HOSPITAL; ISOLATION AND PURIFICATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENDOCARDITIS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 80051660838     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-221     Document Type: Article

References (35)

1. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75-81. 10.1001/jama.288.1.75, 12090865.
2. Ferreiros E, Nacinovich F, Casabe JH, Modenesi JC, Swieszkowski S, Cortes C, Hernan CA, Kazelian L, Varini S. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la Republica Argentina-2 (EIRA-2) Study. Am Heart J 2006, 151:545-552. 10.1016/j.ahj.2005.04.008, 16442929.
3. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001, 345:1318-1330. 10.1056/NEJMra010082, 11794152.
4. Hsu CN, Wang JY, Tseng CD, Hwang JJ, Hsueh PR, Liau CS. Clinical features and predictors for mortality in patients with infective endocarditis at a university hospital in Taiwan from 1995 to 2003. Epidemiol Infect 2006, 134:589-597. 10.1017/S0950268805005224, 2870414, 16238819.
5. Lee CH, Tsai WC, Liu PY, Tsai LM, Ho MT, Chen JH, Lin LJ. Epidemiologic features of infective endocarditis in Taiwanese adults involving native valves. Am J Cardiol 2007, 100:1282-1285. 10.1016/j.amjcard.2007.05.053, 17920371.
6. Loupa C, Mavroidi N, Boutsikakis I, Paniara O, Deligarou O, Manoli H, Saroglou G. Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 2004, 10:556-561. 10.1111/j.1469-0691.2004.00884.x, 15191385.
7. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90-94. 10.1001/archinte.162.1.90, 11784225.
8. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007, 28:196-203.
9. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995, 155:1641-1648. 10.1001/archinte.155.15.1641, 7618988.
10. Moreillon P, Que YA. Infective endocarditis. Lancet 2004, 363:139-149. 10.1016/S0140-6736(03)15266-X, 14726169.
11. Bouza E, Menasalvas A, Munoz P, Vasallo FJ, del Mar Moreno M, Garcia Fernandez MA. Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 2001, 80:298-307.
12. Martin-Davila P, Fortun J, Navas E, Cobo J, Jimenez-Mena M, Moya JL, Moreno S. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005, 128:772-779. 10.1378/chest.128.2.772, 16100166.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140. 10.1016/0196-6553(88)90053-3, 2841893.
14. Benito N, Miro JM, de Lazzari E, Cabell CH, del Rio A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009, 150:586-594.
15. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009, 169:463-473. 10.1001/archinternmed.2008.603, 19273776.
16. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021. 10.1001/jama.293.24.3012, 15972563.
17. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009, 30:2369-2413.
18. Wang JL, Hung CC, Hsieh SM, Chang SC. Clinical features and outcome analysis of infective endocarditis in elderly patients. J Formos Med Assoc 2004, 103:416-421.
19. Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, Lee SW, Lau CP, Tse HF. Emerging trends of community acquired infective endocarditis. Int J Cardiol 2007, 121:119-122. 10.1016/j.ijcard.2006.08.053, 17107721.
20. Huang TY, Tseng HK, Liu CP, Lee CM. Comparison of the clinical manifestations of infective endocarditis between elderly and young patients - a 3-year study. J Microbiol Immunol Infect 2009, 42:154-159.
21. Chao TH, Li YH, Tsai WC, Tsai LM, Lin LJ, Chen JH, Yang YJ. Prognostic determinants of infective endocarditis in the 1990s. J Formos Med Assoc 1999, 98:474-479.
22. Chao TH, Li YH, Tsai WC, Lin LJ, Chen JH, Tsai LM, Luo CY, Yang YJ, Liu PY. Clinical characteristics and prognostic determinants of infective endocarditis in adult intravenous drug users. J Formos Med Assoc 2004, 103:754-760.
23. Lou XF, Yang DY, Liu ZY, Wang HL, Li TS. [Clinical analysis of 120 cases of infective endocarditis]. Zhonghua Nei Ke Za Zhi 2009, 48:35-38.
24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638. 10.1086/313753, 10770721.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
26. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
27. Gilleece A, Fenelon L. Nosocomial infective endocarditis. J Hosp Infect 2000, 46:83-88. 10.1053/jhin.2000.0802, 11049699.
28. Dajani AS, Bisno AL, Chung KJ, Durack DT, Freed M, Gerber MA, Karchmer AW, Millard HD, Rahimtoola S, Shulman ST, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Jama 1990, 264:2919-2922. 10.1001/jama.264.22.2919, 2146414.
29. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209. 10.1016/0002-9343(94)90143-0, 8154507.
30. Ioannidou E, Falagas ME. The difference between adequate and appropriate antimicrobial treatment. Clin Infect Dis 2008, 46:642-644.
31. de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010, 85:422-426. 10.4065/mcp.2009.0585, 2861970, 20435834.
32. Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008, 47:1287-1297. 10.1086/592576, 18834314.
33. Giannitsioti E, Skiadas I, Antoniadou A, Tsiodras S, Kanavos K, Triantafyllidi H, Giamarellou H. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect 2007, 13:763-769. 10.1111/j.1469-0691.2007.01746.x, 17488327.
34. Hricak V, Matejicka F, Sedlak T, Duris I, Milovsky V, Kovacik J, Marks P, West D, Krcmery V. Native valve staphylococcal endocarditis: etiology, risk factors and outcome in 53 cases. J Chemother 1998, 10:360-368.
35. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.